Skip to content

A Multicenter Prospective Clinical Study Comparing the Efficacy of Self-Modified Eversion Carotid Endarterectomy Versus Conventional Eversion Carotid Endarterectomy for the Treatment of Carotid Stenosis.

A Multicenter Prospective Clinical Study Comparing the Efficacy of Self-Modified Eversion Carotid Endarterectomy Versus Conventional Eversion Carotid Endarterectomy for the Treatment of Carotid Stenosis.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500104180
Enrollment
Unknown
Registered
2025-06-12
Start date
2024-06-14
Completion date
Unknown
Last updated
2025-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carotid artery stenosis

Interventions

Control group:Conventional Eversion Carotid Endarterectomy
Experimental group:Self-Modified Eversion Carotid Endarterectomy

Sponsors

The Second affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with carotid artery stenosis degree greater than 70% through CT angiography (CTA) or digital subtraction angiography (DSA); 2. Patients diagnosed by CTA or DSA with carotid artery stenosis degree greater than 50%, and who have experienced ipsilateral cerebral ischemic events in the past six months, such as recurrent TIA attacks; 3. Age under 85 years old; 4. The subjects and their families voluntarily sign a surgical informed consent form.

Exclusion criteria

Exclusion criteria: 1. Asymptomatic patients with carotid artery stenosis less than 70%, or symptomatic patients with carotid artery stenosis less than 50%; 2. Patients with complete occlusion of the carotid artery; 3. Known allergies or contraindications to contrast agents, heparin, antiplatelet drugs, or anesthetics; 4. Imaging examination suggests hemorrhagic transformation after cerebral infarction; 5. Ischemic stroke not caused by carotid artery; 6. The overall condition is poor, with severe infections, low blood volume, or hypotension that cannot tolerate general anesthesia surgery; 7. Life expectancy is less than 2 years; 8. Patients and their families refuse to participate in clinical research.

Design outcomes

Primary

MeasureTime frame
Ipsilateral carotid artery restenosis rate;

Secondary

MeasureTime frame
Total complication rate during the perioperative period.;Carotid artery clamping time during surgery;Improvement in postoperative cerebral ischemic symptoms.;Postoperative blood pressure stability (systolic and diastolic blood pressure).;Rate of patients requiring antihypertensive medication to control blood pressure after surgery;Incidence of postoperative bleeding-related complications;Postoperative sensitivity of the carotid body ventilatory reflex;

Countries

China

Contacts

Public ContactJiehua Qiu

The Second affiliated Hospital of Nanchang University

qiujiehua2010@163.com+86 151 8016 1591

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026